Tags |
|
|
Links |
|
|
E-Articles - Do You Suffer From Irritable Bowel Syndrome Migraine Pain?
There have been a number of studies carried out about the impact of IBS symptoms, including irritable bowel syndrome migraine problems. These studies have shown that peop
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
le who suffer from Irritable Bowel Syndrome are at an increased risk for suffering from migraines, fibromyalgia and depression.
Research has shown there to be an associat
Research has shown there to be an associat
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
on between migraines and functional gastrointestinal disorders.
While there have been previous research done linking Irritable Bowel Syndrome with these disorders, the ma
While there have been previous research done linking Irritable Bowel Syndrome with these disorders, the ma
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ority of the supporting evidence has come from case reports by Dr. J. Alexander Cole and colleagues, from Boston University.
Note: Unfortunately there was no refere
Note: Unfortunately there was no refere
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ce group in these studies. There also was no capability of fully controlling confounding factors. These things prevented these studies from reaching definitive conclusio
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
s.
The most recent study appeared in the September 28, 2006 issue of BMC Gastroenterology. This study involved more than 125,000 subjects and a reference cohort (
The most recent study appeared in the September 28, 2006 issue of BMC Gastroenterology. This study involved more than 125,000 subjects and a reference cohort (
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
group of people sharing the same symptoms).
When these patients were compared to patients who do not have Irritable Bowel Syndrome the patients who had Irritable Bowel S
When these patients were compared to patients who do not have Irritable Bowel Syndrome the patients who had Irritable Bowel S
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ndrome were more than 60% likely to have either depression, migraines and fibromyalgia.
The risks of these individual problems rose as well. For instance, people with Ir
The risks of these individual problems rose as well. For instance, people with Ir
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
itable Bowel Syndrome were 40% more likely to get depression, 60% more likely to get migraines and 80% more likely to get fibromyalgia.
Those patients with Irritable Bowe
Those patients with Irritable Bowe
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
Syndrome and who also suffered from migraines were closely scrutinized. It was discovered that while suffering from a migraine, these people also had various neurologica
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
and vascular symptoms. They also suffered from gastrointestinal disturbances that included nausea, vomiting, abdominal pain or diarrhea.
So, it should come as no surpri
So, it should come as no surpri
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
se that migraine patients have oftentimes reported that they had problems with their bowels. It should also not be a surprise that between 25 to 53% of patients who have
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
rritable Bowel Syndrome state that they frequently have headaches.
Together, migraines and Irritable Bowel Syndrome affect approximately 10 to 20% of the general populati
Together, migraines and Irritable Bowel Syndrome affect approximately 10 to 20% of the general populati
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
n, usually predominantly affecting young adult women. It is believed that the reason why women rather than men are affected is because of the role of estrogen in their bo
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ies.
The nervous system is a source of numerous neurotransmitters and reflexes. This has been linked to why there is a common link between Irritable Bowel Syndrome and m
The nervous system is a source of numerous neurotransmitters and reflexes. This has been linked to why there is a common link between Irritable Bowel Syndrome and m
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
graines. Serotonin, which helps us maintain a "happy feeling," and allows us to control our moods, help with sleep and calm anxiety and relieve stress, is actually the mai
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
neurotransmitter of the gastrointestinal tract.
There are a lot of people who support, and many who are against the use of serotoninergic receptors, which are the most c
There are a lot of people who support, and many who are against the use of serotoninergic receptors, which are the most c
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
mmonly used medications for treating irritable bowel syndrome migraines. These tend to be because of the potential side effects of artificially regulating this natural ho
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
mone.
When heal
Continue reading to discover natural methods to relive IBS symptoms, by signing up for our free newsletter.
When heal
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
h practitioners are better able to understand both of these disorders better, then they will be better equipped to treat all the irritable bowel syndrome migraine symptoms
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/262090/e-article-Do-You-Suffer-From-Irritable-Bowel-Syndrome-Migraine-Pain.html">Do You Suffer From Irritable Bowel Syndrome Migraine Pain?</a>
BB link (for phorums):
[url=http://www.e-article.org.ua/article/262090/e-article-Do-You-Suffer-From-Irritable-Bowel-Syndrome-Migraine-Pain.html]Do You Suffer From Irritable Bowel Syndrome Migraine Pain?[/url]
Related Articles:
6 Aging, Fitness, and Health Myths Debunked-(Myth 5 of 6)
Bookmark it:
|